Company

REPLICEL LIFE SCIENCES INC. (0001205059)

Standardized SEC financial data for REPLICEL LIFE SCIENCES INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001205059 · Biological Products, (No Diagnostic Substances).

Return on equity

12.6%

Income statement

C$	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022
R&D expense	C$2.5M	C$709K	C$2.2M	C$819K	C$1.1M	C$624K
SG&A expense	C$3.5M	C$2.2M	C$1.1M	C$885K	C$1.5M	C$1.1M
Interest expense	—	—	C$0	C$2K	—	—
Net income	-C$6.0M	-C$2.8M	-C$3.0M	-C$1.6M	-C$4.1M	-C$743K

Standardized from REPLICEL LIFE SCIENCES INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

C$	FY2019	FY2019	FY2020	FY2021	FY2021	FY2022
Total assets	C$950K	C$505K	C$421K	—	C$592K	C$798K
Total liabilities	C$4.4M	C$4.9M	C$5.5M	—	C$7.4M	C$6.7M
Retained earnings	-C$35.4M	-C$36.6M	-C$38.2M	—	-C$42.2M

Get 0001205059 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001205059/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001205059/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001205059 filings on SEC EDGAR →